相关实验视频

Updated: Sep 13, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

循环RNA作为开发抗癌疗法的标

Jaewhoon Jeoung¹, Wonho Kim¹, Hyein Jo¹

¹Department of Biochemistry, Kangwon National University, Chuncheon 24341, Republic of Korea.

|July 25, 2025

概括

循环RNAs (CircRNAs) 是稳定的分子,通过增强糖解来驱动癌症的进展和耐药性. 循环RNA疫苗在改善癌症治疗疗效方面表现有前途.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
生物化学生物化学

背景情况:

循环RNAs (CircRNAs) 是由反向拼接形成的RNA分子,以其在细胞过程中的稳定性和调节作用而闻名.
循环RNA与核酸和蛋白质相互作用,影响转录,翻译,新陈代谢和癌症进展.
它们的稳定性和癌症中的参与使得CircRNAs成为有前途的生物标志物和治疗点.

研究的目的:

审查CircRNAs对抗癌药物耐药性的贡献机制,特别是通过增强的葡萄糖分解.
讨论CircRNA疫苗在克服耐药性和改善免疫治疗方面的临床应用.
评估基于CircRNA的疫苗的优缺点.

主要方法:

对癌症中CircRNA功能研究的文献综述.
分析CircRNA在糖解和耐药性中的作用.
审查CircRNA疫苗开发和临床试验数据.

主要成果:

失调的CircRNA表达与各种癌症和抗癌药物耐药性有关.
循环RNAs促进糖解,有助于抵抗化疗剂.
循环RNA疫苗可以诱导免疫反应,并增强对免疫检查点抑制剂的敏感性.

结论:

循环RNAs是抗癌药物耐药性和糖解的关键调节者.
循环RNA疫苗代表了一种新的治疗策略,以克服耐药性并促进免疫治疗.
循环RNA具有在瘤学中作为诊断,预后和治疗工具的巨大潜力.

关键词:

抗癌药物耐药性抗癌药物耐药性癌症的诊断癌症的诊断循环RNA合成的循环RNA合成循环的RNA疫苗是循环的RNA疫苗圆形的RNAs是圆形的RNAs.临床试验是指临床试验中的临床试验.免疫反应的免疫反应.

更多相关视频

Identification of Circular RNAs using RNA Sequencing

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

相关概念视频

Types of RNA

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

siRNA - Small Interfering RNAs

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

RNA Interference

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...